Total
0
Shares
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Xebec Adsorption (XBC) subsidiary Inmatec has received an order for 14 POC medical on-site oxygen generators for hospitals in Moldova
  • Xebec's on-site oxygen generation products improve oxygen supply and delivery by providing an economical means for on-site production
  • On-site oxygen generation provides access to immediate, stable production at up to 60% lower cost and lower carbon emissions
  • Xebec is a global provider of clean energy solutions for renewable and low carbon gases used in energy, mobility and industrial applications
  • Xebec Adsorption (XBC) is up 1.19 per cent, trading at C$4.26 per share at 9:30 am ET

Xebec Adsorption (XBC) subsidiary Inmatec has received an order for 14 POC medical on-site oxygen generators for hospitals in Moldova.

Medical oxygen has seen surging demand as a result of the worldwide COVID-19 pandemic. Oxygen is used by patients with severe symptoms of COVID-19, in addition to patients requiring oxygen for other disease states such as chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF) and asthma.

This new demand has showcased the challenges of securing oxygen from centralized sources.

Xebec is supporting the fight against COVID-19 with its on-site oxygen generation products, which improve the supply and delivery constraints by providing an economical means for on-site production.

By adopting these products, hospitals get access to immediate, stable production at up to 60% lower cost and lower carbon emissions than traditional supply options.

“We are proud to be playing our part in fighting the novel coronavirus. Oxygen shortages continue to be rampant around the world in both developed and developing countries.

Most importantly, Inmatec enables remote hospitals to have economical access to oxygen for patients on ventilators, in operating theatres under anesthesia, and to fill cylinders. Xebec is becoming a key player in distributed gas generation with an aim to lower costs and emissions for customers,” stated Marinus van Driel, President of Xebec Europe.

In response to the pandemic, numerous governments implemented measures, adjusted regulations or made direct investments to secure adequate oxygen production. Inmatec delivered 224 oxygen generators in 2020, up from 118 in the previous year, resulting in revenue more than tripling.

Xebec expects that customers around the world will continue to recognize the benefits of on-site oxygen generation and consequently has delivered (as of March 22, 2021) 66 units in 2021 to customers around the globe and has received orders for another 67 units.

Xebec is a global provider of clean energy solutions for renewable and low carbon gases used in energy, mobility and industrial applications. The company specializes in deploying a portfolio of proprietary technologies for the distributed production of hydrogen, renewable natural gas, oxygen and nitrogen.

Xebec Adsorption (XBC) is up 1.19 per cent, trading at C$4.26 per share at 9:30 am ET.

More From The Market Herald
Neovasc’s (TSX:NVCN) Reducer receives first national European reimbursement

" Neovasc (TSX:NVCN) announces FDA approval of clinical trial

Neovasc (NVCN) has received approval from the FDA for the Investigational Device Exemption regarding its COSIRA-II IDE Clinical Trial.
Cameco (TSX:CCO) to explore small modular reactor collaboration

" Cameco (TSX:CCO) to explore small modular reactor collaboration

Cameco (CCO) is exploring opportunities for the potential deployment, fuelling and servicing of Xe-100 small modular reactors (SMRs).
Relay Medical (CSE:RELA) & Fio to provide rapid COVID-19 testing at TIFF

" ScreenPro (CSE:SCRN) providing COVID-19 testing at TIFF

ScreenPro (SCRN) is providing COVID-19 testing services at this year’s Toronto International Film Festival.
Aurora Spine Corporation (TSXV:ASG) announces $6.5 million private placement

" Aurora Spine Corporation (TSXV:ASG) announces $6.5 million private placement

Aurora Spine Corporation (ASG) has announced a C$6.5 million private placement with institutional investors.